AN OVERVIEW OF EQUITY UTILIZATION IN LIFE SCIENCE COMPANIES THROUGH Q3 2023
DOWNLOAD A COPY OF THIS
REPORT (PDF 1MB)
To our life science industry colleagues,
We are pleased to present the Haigh & Company 2023 BiotechEquity Report. The purpose of our analysis is to provide our clients, colleagues and the broader life sciences community an up-to-date look at equity usage through the third quarter of 2023 and to provide a resource for your year-end and new year planning process. Some Key Results: